Bioavailability of Magnesium Salts – A Review
PDF

Keywords

 Magnesium, citrate, oxide, bioavailability.

How to Cite

Ragnar Rylander. (2014). Bioavailability of Magnesium Salts – A Review. Journal of Pharmacy and Nutrition Sciences, 4(1), 57–59. https://doi.org/10.6000/1927-5951.2014.04.01.8

Abstract

Background: Magnesium supplementation is of value in several different medical disorders. Several kinds of Mg-salts are commercially available.
Purpose: This review evaluates their bioavailability criteria such as solubility, urinary excretion, and plasma levels of magnesium from studies of different Mg-salts.
Conclusion: Although methodology differences were large, the results consistently demonstrate a better bioavailability for Mg-citrate.

https://doi.org/10.6000/1927-5951.2014.04.01.8
PDF

References

Porr PJ, Nechifor M, Durlach J. Advances in magnesium research. John Libbey Eurotext 2006; pp. 1-206.

Rylander R, Tallheden T, Vormann J. Acid-base conditions regulate calcium and magnesium homeostasis. Magnesium Res 2009; 22: 1-4.

Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unseleced German population of 16’000 individuals. Magnesium Res 2001; 14: 283-90.

Vormann J, Anke M. Dietary magnesium supply, requirements and recommendations – results from duplicate and balance studies in man. J Clin Basic Cardiol 2002; 5: 49-53.

Köseoglu Talashoglui A, Grönül S, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magn Res 2008; 21: 101-8.

Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium; results from a prospective, multicentre, placebo-controlled and double blind, randomized study. Cephalgia 1996; 16: 257-63. http://dx.doi.org/10.1046/j.1468-2982.1996.1604257.x

Rylander R, Arnaud MJ. Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels. BMC Public Health 2004; 4: 56-61. http://dx.doi.org/10.1186/1471-2458-4-56

Mooren PC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial. Diab Obesity Metabol 2011; 13: 281-84. http://dx.doi.org/10.1111/j.1463-1326.2010.01332.x

Bullarbo M, Ödman N, Nestler A, Nielsen Y, Kolisek M, Vormann J, Rylander R. Magnesium supplementation to prevent high blood pressure in pregnancy – a randomised placebo control trial. Arch Obstetr Gynecol 2013; 288: 1269-74. http://dx.doi.org/10.1007/s00404-013-2900-2

Sibai BM, Villar MA, Brazy E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstetr Gynecol 1989; 161: 115-19. http://dx.doi.org/10.1016/0002-9378(89)90246-9

Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol 2010; 298: C407-29. http://dx.doi.org/10.1152/ajpcell.00124.2009

Kolisek M, Launay P, Beck A, Sponder G, Serafini N, Brenkus M, et al. SLC41A1 is a novel mammalian Mg2+ carrier. J Biol Chem 2008; 283: 16235-47. http://dx.doi.org/10.1074/jbc.M707276200

Wilimzig C, Latz R, Vierling W, Mutschler E, Trnovec T, Nyulassy S. Increase in magnesium plasma level after orally administered trimagnesium dicitrate. Eur J Clin Pharmacol 1996; 49: 317-23. http://dx.doi.org/10.1007/BF00226334

Jahnen A, Scharrel O, Hesse A. The availability of magnesium compounds from various preparations, In Lasserre B and Durlach J (eds) Magnesium – a relevant ion. Libbey 1991; pp. 377-82.

Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Res 2001; 14: 257-62.

Lindberg JS, Zobits MM, Poindexter JR, Pak CY. Magnesium bioavailablity from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990; 9: 48-55. http://dx.doi.org/10.1080/07315724.1990.10720349

Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol 1981; 40: 437-38. http://dx.doi.org/10.1007/BF00265863

Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium Res 2003; 16: 183-91.

Bøhmer T, Røseth A, Holm H, Weberg-Teigen S, Wahl L. Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnesium Trace Elem 1990; 9: 272-78.

Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnesium Res 2012; 25: 28-39.

Nestler A, Vormann J, Kolisek M. Magnesium supplementation acutely affects intracellular Mg2+ in human leukocytes. FASEB J 2012; 26: lb278.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2014 Ragnar Rylander